TrialPloS one2011

Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children.

Patrick Georges Cech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.